Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends
Running, not enrolling · Not applicable
Conditions studied: Symptomatic Neuroma, Amputation, Chronic Nerve Pain
In brief
This pilot study evaluates the tolerability and feasibility of the Axoguard Large-Diameter Nerve Cap (sizes 5-7 mm) for protecting and preserving terminated nerve endings after limb trauma or amputation when immediate attention to the nerve injuries is not possible.
Key facts
- Study ID
- NCT04865679
- Run by
- Axogen Corporation
- People needed
- 15
- Starts
- 2022-03-02
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-06-03
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Texas Tech University, Health Science Center — Lubbock, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.